argenx SE

ARGX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$830.79-2.70%

2026-08-03

Financials

Valuation Metrics

argenx SE's Market Cap is $51.92B. At end of 2025 it was $51.65B. Ranked #314 of 3,112 in US market (top 10%), #85 of 1,445 on NASDAQ (top 6%), #17 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 6%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$51.92B	US#314/3,112 Sec#17/269
Revenue	$6.46B	US#765/3,112 Sec#24/269
Net Income	$2.30B	US#293/3,112 Sec#18/269
Total Assets	$10.03B	US#980/3,112 Sec#29/269
Net Assets	$8.42B	US#488/3,112 Sec#20/269
Value
P/E	22.57x	US#1,173/3,112 Sec#41/269
P/B	6.17x	US#2,328/3,112 Sec#160/269
P/S	8.04x	US#2,572/3,112 Sec#112/269
EV/EBITDA	24.05x	US#2,022/3,112 Sec#62/269
Profitability
ROE	27.33%	US#350/3,112 Sec#25/269
ROA	22.93%	US#62/3,112 Sec#15/269
Op. Margin	26.16%	US#606/3,112 Sec#30/269
Revenue Growth	12.53%	US#1,101/3,112 Sec#88/269
Earnings Growth	-3.09%	US#1,454/3,112 Sec#44/269
Financial Health
Debt Ratio	19.19%	US#213/3,112 Sec#76/269
Total Debt	$47M	US#2,559/3,112 Sec#150/269
Cash	$3.58B	US#262/3,112 Sec#17/269
Current Ratio	5.12x	US#456/3,112 Sec#142/269
Net Debt/EBITDA	-1.76x	US#198/3,112 Sec#14/269
Performance
1Y Return	23.30%	US#1,455/3,112 Sec#163/269
1M Return	-11.59%	US#2,680/3,112 Sec#183/269
From 52W High	-12.88%	US#1,262/3,112 Sec#73/269
1Y MDD	-28.58%	US#1,277/3,112 Sec#79/269
Trading
Volume	242,443 shares	US#2,549/3,112 Sec#246/269
Trading Value	$202M	US#520/3,112 Sec#28/269
Per Share
EPS	$35.09	US#28/3,112 Sec#2/269
BPS	$119.23	US#77/3,112 Sec#6/269